Navigation Links
CEO Addresses Fort Worth Business Leaders About Developing Pandemic and Business Continuity Plans
Date:5/16/2008

g operations as a result of an increased level of absenteeism due to illness, employees caring for the sick and social-distancing policies. In Texas alone, there is the potential for more than 6.7 million employees to be absent from their jobs, according to the Trust for America's Health report, resulting in losses of roughly $23.6 billion dollars due to absenteeism and death.

Based on his experience in working with the federal government the past several years on pandemic preparedness, Abercrombie reminded the audience that the government has asked private businesses to share in the responsibility of planning. While the federal government has plans to help slow the spread of the virus among critical populations, such as healthcare workers and emergency personnel, it is up to local communities and businesses to ensure that residents and employees stay healthy and that businesses and local economies remain up and running.

More information on how businesses can organize their own pandemic plans is available online at http://www.pandemictoolkit.com. For more information about the Trust for America's Health, visit http://healthyamericans.org/reports/flurecession/releases/TN.pdf.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company t
'/>"/>

SOURCE Hoffmann-La Roche Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Publication Addresses Misconceptions About Emergency Contraception
2. MIT researcher addresses biomedical engineering challenges
3. VaxGen Addresses MPM Claims in Letter to Stockholders
4. Free White Paper Addresses Challenges of New FDA Regulations Awaiting Combo Product Manufacturers
5. Abingworth Appoints David Mayer as Partner
6. Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN
7. Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
8. ProMetic provides business update - Over $35 million worth of business secured in January
9. Vermillion Announces First Quarter 2008 Financial Results and Business Progress
10. ThromboGenics N.V. - Business Update
11. MedApps Selected as Dell-NFIB 2008 Business Excellence Award Finalist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Follow us on LinkedIn –Cholesterol ... cholesterol carrier or lipoprotein in the blood. Such tests ... in the body, especially along the walls of blood ... other cardiovascular disorders. Cardiovascular Diseases (CVD) is the leading ... on a regular basis, to assess an individual’s risk ...
(Date:9/30/2014)... 2014 CORD:USE Cord Blood Bank – ... has entered into an Equity and Exclusive Services Agreement ... series of patented technologies for the isolation of human ... Tianhe is performing Phase I/II clinical trials in ... using Tianhe,s Stem Cell Educator Therapy showing that ...
(Date:9/30/2014)... Switzerland (PRWEB) September 30, 2014 ... software solutions for drug discovery and related ... FUNGITECT consortium has chosen Genedata Selector as ... sequencing (NGS) data. FUNGITECT is a European ... invasive fungal diseases via individualized anti-fungal drug ...
(Date:9/30/2014)...  KemPharm, Inc., a clinical-stage specialty pharmaceutical company ... new molecular entity (NME) prodrugs, announced today that ... issued U.S. Patent No. 8,816,083 to KemPharm for ... Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, ... The patent, which extends through 2032, provides ...
Breaking Biology Technology:Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2
... Non-HDL and apoB measurement helps physicians guide therapy for ... cardiometabolic ... of LDL,non-HDL and apoB are now recognized as valid, accurate ... for patients with,cardiometabolic risk (CMR). The VAP(R) Cholesterol Test (Atherotech, ...
... - CuraGen to receive approximately $45 million in cash, stock and future ... milestone payments ... Provides updated financial guidance for 2008 - ... BRANFORD, Conn., April 22 CuraGen Corporation,(Nasdaq: CRGN ), a clinical-stage ...
... April 22 /Xinhua-PRNewswire/ -- Fufeng Group Limited,("Fufeng" or ... "the Group"; HKEx: 546), a leading vertically integrated,manufacturer ... results for the year ended 31 December 2007., ... sales volume of major,products, the Group,s turnover increased ...
Cached Biology Technology:Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients 2Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients 3CuraGen Sells Ownership of Belinostat to TopoTarget A/S 2CuraGen Sells Ownership of Belinostat to TopoTarget A/S 3CuraGen Sells Ownership of Belinostat to TopoTarget A/S 4CuraGen Sells Ownership of Belinostat to TopoTarget A/S 5Fufeng Announces 2007 Annual Results 2Fufeng Announces 2007 Annual Results 3
(Date:9/30/2014)... most comprehensive assessment conducted by the Ocean Health ... of 100 in overall health. In addition, for ... and the 15 ocean regions beyond national jurisdiction ... a healthy climate, safeguarding biodiversity and providing sustainable ... of the index, a partnership led by scientists ...
(Date:9/30/2014)... led by Clemson University associate professor Brian Powell, ... the U.S. Department of Energy,s Experimental Program to ... impact on South Carolina in the advancement of ... "Understanding the scientific and engineering needs for safely ... technologies is imperative if South Carolina is to ...
(Date:9/30/2014)... -- Pollution in urban and farm runoff in Hawaii ... study finds. , The study, published Tuesday in ... nitrogen in the runoff ends up in algae that ... the animals, eyes, flippers and internal organs. , Scientists ... National Oceanic and Atmospheric Administration (NOAA) conducted the study ...
Breaking Biology News(10 mins):Rating the planet's oceans 2Rating the planet's oceans 3Researchers get $5.25 million to advance nuclear technologies in South Carolina 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3
... Philadelphia, PA, December 12, 2012 Cell aging, or ... physiological response to tumor development. Activated oncogenes are able ... oncogene-induced senescence (OIS) could play a key role in ... unknown mechanism in the regulation of OIS. This study ...
... WINSTON-SALEM, N.C., Dec. 11, 2012 When Teresa Thorn started ... something she,d had years earlier. As the days ... changing, something her co-workers noticed. Finally one Sunday, she and ... Wake Forest Baptist Medical Center, where a battery of tests ...
... research, presented this morning at the 54th Annual ... identified important associations between Plasmodium falciparum ... help researchers identify young children who are more susceptible ... malaria infection alone was considered the important factor, this ...
Cached Biology News:Previously unknown mechanism identified in oncogene-induced senescence 2Vaccine offers promise as post-surgery treatment for pancreatic cancer patients 2Vaccine offers promise as post-surgery treatment for pancreatic cancer patients 3Vaccine offers promise as post-surgery treatment for pancreatic cancer patients 4New research helps predict susceptibility to Burkitt lymphoma 2
MOUSE ANTI BOVINE TROPONIN I...
Ready-to-use; 40mg/ml X-Gal and 32mg/ml IPTG...
Normal donkey serum collected from healthy normal donkeys....
This BioSolution package is excellent for doing fluorescence thermal melt experiments on nucleic acids, studies involving biomolecular interactions, protein folding experiments, and more!...
Biology Products: